Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-00602
Authors: Jian Zhang, Quchang Ouyang, Qingyuan Zhang, Huihui Li, Xu Wang, Ying Wang, Yongmei Yin, Shusen Wang, Yuanting Gu, Tao Sun, Jingfen Wang, Xinhong Wu, Fanfan Li, Xi Chen, Man Li, Jin Yang, Hua Yang, Zhengkui Sun, Jianyun Nie, Xiaojia Wang, Jian Liu, Xianjun Tang, Hao Wang, Zhan Huang, Weimin Xie, Wenyan Chen, Fan Li, Yuee Teng, Shuqun Zhang, Ru Zeng, Wenhui Wang, Lixia Ma, Yongli Gao, Haijun Yu, Xiguang Cao, Yan Qing, Xiaoping Jin, Junyou Ge, Hongxia Wang, Xichun Hu
Institutions: Fudan University, Fudan University Shanghai Cancer Center, Hunan Cancer Hospital, Third Affiliated Hospital of Harbin Medical University, Shandong Tumor Hospital, Shandong First Medical University, Tianjin Medical University Cancer Institute and Hospital, Zhejiang Cancer Hospital, Tianjin Medical University, Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Jiangsu Province Hospital, Nanjing Medical University, Sun Yat-sen University Cancer Center, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, Liaoning Cancer Hospital & Institute, China Medical University, Hubei Cancer Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Second Affiliated Hospital of Anhui Medical University, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Xi'an Jiaotong University, Affiliated Hospital of Hebei University, Jiangxi Provincial Cancer Hospital, Fujian Provincial Cancer Hospital, Chongqing University, Chongqing Cancer Hospital, Sichuan Cancer Hospital, Yue Bei People's Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, First Hospital of China Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Xiamen University, Weifang People's Hospital, Jilin Province Tumor Hospital, Linyi People's Hospital, Wuhan University, Zhongnan Hospital of Wuhan University, Kelun Group (China)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7212223268